Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial

A. S. Christensen; S. Haedersdal; J. Stoy; H. Storgaard; U. Kampmann; M. Seghieri; J. J. Holst; T. Hansen; F. K. Knop; T. Vilsboll

Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial

A. S. Christensen, S. Haedersdal, J. Stoy, H. Storgaard, U. Kampmann, M. Seghieri, J. J. Holst, T. Hansen, F. K. Knop, T. Vilsboll

Original language	English
Publication date	Sept 2020
Publication status	Published - Sept 2020

Cite this

@conference{8be5f54796224cfe9055af6e726c034b,

title = "Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial",

author = "Christensen, {A. S.} and S. Haedersdal and J. Stoy and H. Storgaard and U. Kampmann and M. Seghieri and Holst, {J. J.} and T. Hansen and Knop, {F. K.} and T. Vilsboll",

year = "2020",

month = sep,

language = "English",

pages = "S78--S79",

}

TY - ABST

T1 - Linagliptin as add-on treatment to glimepiride in patients with HNF1A-diabetes (MODY3): a randomised, double-blinded, placebo-controlled, crossover trial

AU - Christensen, A. S.

AU - Haedersdal, S.

AU - Stoy, J.

AU - Storgaard, H.

AU - Kampmann, U.

AU - Seghieri, M.

AU - Holst, J. J.

AU - Hansen, T.

AU - Knop, F. K.

AU - Vilsboll, T.

PY - 2020/9

Y1 - 2020/9

M3 - Conference abstract for conference

SP - S78-S79

ER -